1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer
Main Authors: | María Hernández, Simon Dohrmann, James Levin, Nicholas Dedeic, Amanda Almaguer, Doug Zuill, Elizabeth Abelovski, Rajvir Grewal, Joanne Fortier, Qiping Zhao, Karin Amundson, Madison Moniz, Hongyuan Chen, Dhanya Panicker, Thanh Lam, Thomas P Brady, Allen Borchardt, Jason N Cole, Leslie W Tari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Two-component signal transduction system CBO0787/CBO0786 represses transcription from botulinum neurotoxin promoters in Clostridium botulinum ATCC 3502.
by: Zhen Zhang, et al.
Published: (2013-03-01) -
Dataflow approach to testing Java programs supported with DFC
by: Ilona Bluemke, et al.
Published: (2015-06-01) -
Razões para substituir DOAR pela DFC: o caso brasileiro
by: Nilton da Rocha, et al.
Published: (2002-07-01) -
CBO Richtlijn Preventie van valincidenten bij ouderen: wat kunnen verpleeghuizen hiermee?
by: JCL Neyens, et al.
Published: (2024-01-01) -
Optimization of critical slip surface in unsaturated slopes subjected to rain infiltration by CBO algorithm
by: Sh. Sadat Naseri, et al.
Published: (2022-08-01)